Pain and sedation management for screening or treatment of retinopathy of prematurity
- PMID: 40331444
- PMCID: PMC12056892
- DOI: 10.1002/14651858.CD016171
Pain and sedation management for screening or treatment of retinopathy of prematurity
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of pain and sedation management for screening or treatment of retinopathy of prematurity in preterm infants compared to placebo, no intervention, or other interventions.
Copyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.
Conflict of interest statement
EO: no commercial or non‐commercial conflicts of interest relevant to this review.
OR: no commercial or non‐commercial conflicts of interest relevant to this review.
PL: no commercial or non‐commercial conflicts of interest relevant to this review.
MF: is the Managing Editor and Information Specialist of Cochrane Neonatal; she did not participate in the editorial assessment or acceptance of this review.
AS: no commercial or non‐commercial conflicts of interest relevant to this review.
AH: no commercial or non‐commercial conflicts of interest relevant to this review.
MB: is an Associate Editor for Cochrane Neonatal; he did not participate in the editorial assessment or acceptance of this review.
Similar articles
-
Dexmedetomidine for analgesia and sedation for procedural pain or discomfort in newborn infants.Cochrane Database Syst Rev. 2025 Jan 28;1(1):CD014212. doi: 10.1002/14651858.CD014212. Cochrane Database Syst Rev. 2025. PMID: 39873291 Free PMC article.
-
Retinopathy of prematurity: A refresher for obstetricians.Int J Fertil Womens Med. 2006 Mar-Apr;51(2):89-96. Int J Fertil Womens Med. 2006. PMID: 16881385 Review.
-
Retinopathy of prematurity prevention, screening and treatment programmes: The role of neonatal networks.Semin Perinatol. 2019 Oct;43(6):341-343. doi: 10.1053/j.semperi.2019.05.005. Epub 2019 May 11. Semin Perinatol. 2019. PMID: 31155226 Review.
-
Retinopathy of prematurity prevention, screening and treatment programmes: Progress in India.Semin Perinatol. 2019 Oct;43(6):344-347. doi: 10.1053/j.semperi.2019.05.006. Epub 2019 May 11. Semin Perinatol. 2019. PMID: 31174875 Review.
-
Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening.J Perinatol. 2010 Nov;30(11):731-5. doi: 10.1038/jp.2010.36. Epub 2010 Mar 18. J Perinatol. 2010. PMID: 20237484 Clinical Trial.
References
-
- Royal College of Paediatrics and Child Health. UK Screening of retinopathy of prematurity guideline. http://www.rcpch.ac.uk/resources/screening-retinopathy-prematurity-rop-c... (accessed 1 September 2024).
-
- Krohne TU, Camp AT, Pfeil JM, Müller A, Stahl A, Lagrèze WA, et al; EU-ROP Registry Study Group. Retinopathy of prematurity in Germany over 13 years: incidences, treatment preferences and effects of national guideline changes. Archives of Disease in Childhood. Fetal & Neonatal Edition 2024;110(1):37-42. [DOI: 10.1136/archdischild-2024-327133] [PMID: ] - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical